Fourth time is a charm for Snap. Shares soared over 45% after finally delivering an earnings report that impressed Wall Street. Daniel Ives, Chief Strategy Officer at GBH Insights, joined to discuss the report, as well as earnings results from Chipotle and Disney.
Snap shocked Wall Street after posting revenue of $285.7 million. Ives said it's the first step in the right direction toward a turnaround story. If Snap can get its act together, he can see it being a low-to-mid $20 stock. Ives said one quarter doesn't make a trend and that it's a huge "prove me" period for Spiegel and company to show that the turnaround is for real.
Disney announced it will price ESPN Plus, the company's first direct-to-consumer streaming service, at $4.99 per month. He said the new service, along with the deal for 21st Century Fox, will make the company a legitimate streaming player.
Chipotle continues to struggle to win back customers after the food-borne illness outbreaks. If Chipotle's stock falls another 15%-25%, Ives said it would be an attractive takeover target.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
